cbdMD, Inc.
YCBD · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | -1.98 | 0.02 |
| FCF Yield | -13.68% | -479,542.65% | -3.53% | 0.35% |
| EV / EBITDA | -11.09 | 0.98 | 52.64 | 30.80 |
| Quality | ||||
| ROIC | -12.79% | -26.83% | 165.30% | -9.79% |
| Gross Margin | 61.45% | 62.31% | 66.50% | 53.85% |
| Cash Conversion Ratio | 0.79 | 1.09 | -21.06 | -1.10 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.23% | -12.03% | -15.77% | -18.05% |
| Free Cash Flow Growth | 99.90% | -142,297.97% | -940.64% | -80.20% |
| Safety | ||||
| Net Debt / EBITDA | 0.21 | 1.28 | -1.36 | -2.42 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.63 | 0.67 | 0.81 | 0.89 |
| Cash Conversion Cycle | 99.04 | 89.06 | 72.58 | 54.71 |